nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.237	0.601	CbGbCtD
Amcinonide—NR3C1—Progesterone—uterine cancer	0.157	0.398	CbGbCtD
Amcinonide—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.067	0.127	CrCrCtD
Amcinonide—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.0608	0.115	CrCrCtD
Amcinonide—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.059	0.112	CrCrCtD
Amcinonide—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0542	0.103	CrCrCtD
Amcinonide—Cortisone acetate—Progesterone—uterine cancer	0.053	0.1	CrCrCtD
Amcinonide—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0528	0.1	CrCrCtD
Amcinonide—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.049	0.0928	CrCrCtD
Amcinonide—Fluoxymesterone—Progesterone—uterine cancer	0.0473	0.0895	CrCrCtD
Amcinonide—Fludrocortisone—Progesterone—uterine cancer	0.046	0.0871	CrCrCtD
Amcinonide—Prednisolone—Progesterone—uterine cancer	0.0391	0.074	CrCrCtD
Amcinonide—ANXA1—oviduct—uterine cancer	0.0101	0.186	CbGeAlD
Amcinonide—ANXA1—exocrine gland—uterine cancer	0.00585	0.107	CbGeAlD
Amcinonide—ANXA1—myometrium—uterine cancer	0.00324	0.0596	CbGeAlD
Amcinonide—ANXA1—epithelium—uterine cancer	0.00254	0.0467	CbGeAlD
Amcinonide—ANXA1—uterine cervix—uterine cancer	0.00252	0.0463	CbGeAlD
Amcinonide—ANXA1—smooth muscle tissue—uterine cancer	0.00245	0.045	CbGeAlD
Amcinonide—ANXA1—decidua—uterine cancer	0.0024	0.0442	CbGeAlD
Amcinonide—ANXA1—renal system—uterine cancer	0.00236	0.0434	CbGeAlD
Amcinonide—ANXA1—endometrium—uterine cancer	0.00228	0.0419	CbGeAlD
Amcinonide—ANXA1—mammalian vulva—uterine cancer	0.00221	0.0405	CbGeAlD
Amcinonide—ANXA1—uterus—uterine cancer	0.0021	0.0386	CbGeAlD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.00196	0.0901	CbGpPWpGaD
Amcinonide—ANXA1—female reproductive system—uterine cancer	0.00189	0.0347	CbGeAlD
Amcinonide—ANXA1—female gonad—uterine cancer	0.00172	0.0316	CbGeAlD
Amcinonide—ANXA1—vagina—uterine cancer	0.00171	0.0314	CbGeAlD
Amcinonide—NR3C1—myometrium—uterine cancer	0.00113	0.0207	CbGeAlD
Amcinonide—ANXA1—lymph node—uterine cancer	0.00111	0.0203	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00109	0.05	CbGpPWpGaD
Amcinonide—NR3C1—epithelium—uterine cancer	0.000883	0.0162	CbGeAlD
Amcinonide—NR3C1—uterine cervix—uterine cancer	0.000876	0.0161	CbGeAlD
Amcinonide—NR3C1—smooth muscle tissue—uterine cancer	0.000851	0.0156	CbGeAlD
Amcinonide—NR3C1—decidua—uterine cancer	0.000835	0.0153	CbGeAlD
Amcinonide—NR3C1—renal system—uterine cancer	0.000819	0.0151	CbGeAlD
Amcinonide—NR3C1—endometrium—uterine cancer	0.000792	0.0146	CbGeAlD
Amcinonide—NR3C1—mammalian vulva—uterine cancer	0.000766	0.0141	CbGeAlD
Amcinonide—NR3C1—uterus—uterine cancer	0.00073	0.0134	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	0.000713	0.0328	CbGpPWpGaD
Amcinonide—NR3C1—female reproductive system—uterine cancer	0.000656	0.0121	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000606	0.0279	CbGpPWpGaD
Amcinonide—NR3C1—female gonad—uterine cancer	0.000597	0.011	CbGeAlD
Amcinonide—NR3C1—vagina—uterine cancer	0.000594	0.0109	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	0.000579	0.0266	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PGR—uterine cancer	0.000471	0.0217	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.000449	0.0207	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—HNF1B—uterine cancer	0.000438	0.0202	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR2—uterine cancer	0.000415	0.0191	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—STK11—uterine cancer	0.000395	0.0182	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	0.000395	0.0182	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000389	0.0179	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—PGR—uterine cancer	0.000386	0.204	CrCbGaD
Amcinonide—NR3C1—lymph node—uterine cancer	0.000384	0.00706	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000372	0.0171	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000361	0.0166	CbGpPWpGaD
Amcinonide—Betamethasone—PGR—uterine cancer	0.000354	0.187	CrCbGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000328	0.0151	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000327	0.0151	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000294	0.0135	CbGpPWpGaD
Amcinonide—Fluoxymesterone—ESR1—uterine cancer	0.000287	0.152	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCL2—uterine cancer	0.000283	0.013	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—EZH2—uterine cancer	0.000281	0.0129	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP11A1—uterine cancer	0.000273	0.145	CrCbGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	0.000264	0.0122	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IRF1—uterine cancer	0.00026	0.012	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—uterine cancer	0.000252	0.0116	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR1—uterine cancer	0.000252	0.0116	CbGpPWpGaD
Amcinonide—Betamethasone—CYP19A1—uterine cancer	0.000243	0.128	CrCbGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	0.00023	0.0106	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—uterine cancer	0.000224	0.0103	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000219	0.0101	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CDKN1B—uterine cancer	0.000219	0.0101	CbGpPWpGaD
Amcinonide—Dexamethasone—PGR—uterine cancer	0.000206	0.109	CrCbGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.000199	0.00915	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—SMAD3—uterine cancer	0.000194	0.00891	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL2—uterine cancer	0.000193	0.00891	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	0.000184	0.00849	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HMGA1—uterine cancer	0.000176	0.00811	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	0.00017	0.00781	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	0.000168	0.00775	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	0.000165	0.00761	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000161	0.00739	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EP300—uterine cancer	0.000158	0.00726	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ESR1—uterine cancer	0.000154	0.00711	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	0.000153	0.00706	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—uterine cancer	0.000153	0.00704	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	0.000149	0.00687	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000149	0.00685	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000145	0.00669	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP19A1—uterine cancer	0.000141	0.0747	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.00014	0.00647	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—uterine cancer	0.000137	0.00632	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	0.000137	0.00632	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000137	0.0063	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	0.000136	0.00626	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000134	0.00617	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SOCS3—uterine cancer	0.000132	0.00607	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000131	0.00601	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	0.00013	0.00597	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—uterine cancer	0.000129	0.00594	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	0.000127	0.00584	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKR1B10—uterine cancer	0.000124	0.00573	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000124	0.00569	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	0.000118	0.00545	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SMAD3—uterine cancer	0.000115	0.00531	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	0.000115	0.0053	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—uterine cancer	0.000113	0.00519	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—EP300—uterine cancer	0.000112	0.00514	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—uterine cancer	0.000111	0.00512	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	0.000107	0.00495	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000105	0.00484	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	0.000105	0.00483	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RNF43—uterine cancer	0.000103	0.00475	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	0.000103	0.00472	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	0.000101	0.00467	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	9.91e-05	0.00456	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL2—uterine cancer	9.88e-05	0.00455	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—uterine cancer	9.82e-05	0.00452	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	9.66e-05	0.00445	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.66e-05	0.00445	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	9.56e-05	0.0044	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	9.52e-05	0.00438	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	9.46e-05	0.00436	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INHBA—uterine cancer	9.43e-05	0.00434	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.34e-05	0.0043	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	9.21e-05	0.00424	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	8.79e-05	0.00405	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PHF1—uterine cancer	8.73e-05	0.00402	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKR1C1—uterine cancer	8.49e-05	0.00391	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	8.2e-05	0.00377	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	8.13e-05	0.00374	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	8.12e-05	0.00374	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	8.07e-05	0.00372	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.89e-05	0.00363	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—uterine cancer	7.81e-05	0.0036	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CHD4—uterine cancer	7.42e-05	0.00342	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	6.59e-05	0.00304	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKR1C3—uterine cancer	6.54e-05	0.00301	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	6.43e-05	0.00296	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PGR—uterine cancer	6.37e-05	0.00293	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SUZ12—uterine cancer	6.22e-05	0.00286	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—YWHAE—uterine cancer	6.08e-05	0.0028	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CTNNB1—uterine cancer	6.04e-05	0.00278	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FBXW7—uterine cancer	5.83e-05	0.00268	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	5.81e-05	0.00267	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	5.66e-05	0.00261	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	5.66e-05	0.00261	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	5.22e-05	0.0024	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STK11—uterine cancer	5.09e-05	0.00235	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL2—uterine cancer	5.07e-05	0.00233	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	4.95e-05	0.00228	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	4.9e-05	0.00226	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	4.85e-05	0.00223	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SOCS3—uterine cancer	4.77e-05	0.0022	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	4.61e-05	0.00212	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	4.59e-05	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN2B—uterine cancer	4.57e-05	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—uterine cancer	4.43e-05	0.00204	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—uterine cancer	4.41e-05	0.00203	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	4.21e-05	0.00194	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMAD3—uterine cancer	4.17e-05	0.00192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—uterine cancer	4.01e-05	0.00185	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR2—uterine cancer	3.98e-05	0.00183	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	3.43e-05	0.00158	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—uterine cancer	3.4e-05	0.00157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NRAS—uterine cancer	3.22e-05	0.00148	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PGR—uterine cancer	3.1e-05	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL2—uterine cancer	2.99e-05	0.00138	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EZH2—uterine cancer	2.94e-05	0.00135	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—uterine cancer	2.8e-05	0.00129	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—uterine cancer	2.77e-05	0.00127	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR2—uterine cancer	2.73e-05	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—uterine cancer	2.54e-05	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—uterine cancer	2.5e-05	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—uterine cancer	2.37e-05	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—uterine cancer	2.35e-05	0.00108	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1B—uterine cancer	2.31e-05	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—uterine cancer	2.29e-05	0.00105	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CDKN2B—uterine cancer	2.22e-05	0.00102	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNB1—uterine cancer	2.18e-05	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—uterine cancer	2.13e-05	0.00098	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—uterine cancer	2.08e-05	0.000956	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EP300—uterine cancer	2.03e-05	0.000935	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SMAD3—uterine cancer	2.03e-05	0.000933	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—uterine cancer	1.92e-05	0.000885	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRAS—uterine cancer	1.9e-05	0.000875	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—uterine cancer	1.65e-05	0.000761	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—uterine cancer	1.63e-05	0.000753	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—uterine cancer	1.5e-05	0.000692	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—uterine cancer	1.45e-05	0.000669	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—uterine cancer	1.39e-05	0.00064	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—uterine cancer	1.23e-05	0.000565	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—uterine cancer	5.96e-06	0.000275	CbGpPWpGaD
